Zhixing Zhou
Tianjin Key Laboratory Of Molecular Design And Drug Discovery
Tianjin, 300193, China
Tianjin, 300193, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
A new hypoglycemic mechanism of catalpol revealed by enhancing MyoD/MyoG-mediated myogenesis.
Journal: Life sciences
Published: June 09, 2018
Glycyrrhetic Acid Derivative TY501 Protects Against Lithocholic Acid-Induced Cholestasis.
Journal: Drug research
Published: December 05, 2017
Discovery of a Flexible Triazolylbutanoic Acid as a Highly Potent Uric Acid Transporter 1 (URAT1) Inhibitor.
Journal: Molecules (Basel, Switzerland)
Published: October 24, 2016
Discovery of Flexible Naphthyltriazolylmethane-based Thioacetic Acids as Highly Active Uric Acid Transporter 1 (URAT1) Inhibitors for the Treatment of Hyperuricemia of Gout.
Journal: Medicinal chemistry (Shariqah (United Arab Emirates))
Published: April 25, 2016
Potent tumor targeting drug release system comprising MMP-2 specific peptide fragment with self-assembling characteristics.
Journal: Drug design, development and therapy
Published: October 25, 2014
Long-acting GLP-1 analogue in V-shaped conformation by terminal polylysine modifications.
Journal: Molecular pharmaceutics
Published: September 23, 2014
Study on hepatotoxicity of aqueous extracts of Polygonum multiforum in rats after 28-day oral administration-analysis on correlation of cholestasis
Journal: Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica
Published: August 07, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026